Daniel Tillett

Daniel Tillett

Chief Executive Officer at RACE ONCOLOGY LIMITED

Net worth: 11 M $ as of 2024-04-29

Consumer Services
Health Technology
Technology Services

Network origin in Daniel Tillett first degree

EntityEntity typeIndustry
Public Company Pharmaceuticals: Major 19
Public Company Packaged Software 2

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Daniel Tillett via their personal network

CompanySectorRelated peopleMain position
ASTRAZENECA PLC Pharmaceuticals: Major

Tim Hammond

Corporate Officer/Principal

RESP HEAL Packaged Software

Christopher Ntoumenopoulos

Director/Board Member

BOTANIX PHARMACEUTICALS LIMITED Pharmaceuticals: Major

Daniel Sharp

Director/Board Member

College/University

Peter Laurence Molloy

Mary Harney

Undergraduate Degree

Undergraduate Degree

Electric Utilities

Darryl Flukes

Chief Executive Officer

Karolinska Institutet College/University

Borje Andersson

Undergraduate Degree

Miscellaneous Commercial Services

Michael Kelso

Corporate Officer/Principal

PHARMING GROUP N.V. Pharmaceuticals: Major

Damian Clarke-Bruce

Sales & Marketing

FIRST LITHIUM LIMITED Other Metals/Minerals

Christopher Ntoumenopoulos

Director/Board Member

College/University

Daniel Sharp

Phillip Lynch

Mary Harney

Graduate Degree

Undergraduate Degree

Undergraduate Degree

TRIVARX LIMITED Packaged Software

Christopher Ntoumenopoulos

Director/Board Member

Pharmaceuticals: Major

Peter Smith

Mary Harney

Chief Executive Officer

Corporate Secretary

The University of New South Wales College/University

Damian Clarke-Bruce

Undergraduate Degree

Macquarie University College/University

Damian Clarke-Bruce

Graduate Degree

The University of Queensland College/University

Michael Kelso

Doctorate Degree

The University of Sydney College/University

Marinella Messina

Damian Clarke-Bruce

Doctorate Degree

Graduate Degree

Other Consumer Services

Borje Andersson

Corporate Officer/Principal

University of Wollongong College/University

Michael Kelso

Undergraduate Degree

The University of Western Australia College/University

Christopher Ntoumenopoulos

Undergraduate Degree

Miscellaneous Commercial Services

Peter Webse

Mary Harney

Christina Manfre

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

IMPEDIMED LIMITED Medical Specialties

Daniel Sharp

Director/Board Member

DIMERIX LIMITED Pharmaceuticals: Major

Peter Webse

David Fuller

Director/Board Member

Chief Tech/Sci/R&D Officer

Royal Australian Chemical Institute, Inc.

Michael Kelso

Corporate Officer/Principal

Pharmaceuticals: Major

Peter Laurence Molloy

Corporate Officer/Principal

Investment Banks/Brokers

Daniel Sharp

Corporate Officer/Principal

Miscellaneous Commercial Services

Darryl Flukes

Director/Board Member

Biotechnology

Peter Laurence Molloy

Chief Executive Officer

ALCIDION GROUP LIMITED Packaged Software

Daniel Sharp

Director/Board Member

ADALTA LIMITED Biotechnology

David Fuller

Director/Board Member

Investment Banks/Brokers

Daniel Sharp

Director/Board Member

PARNELL PHARMACEUTICALS HOLDINGS LTD Pharmaceuticals: Major

Peter Laurence Molloy

Director/Board Member

FIREBRICK PHARMA LIMITED Pharmaceuticals: Major

Peter Laurence Molloy

Chief Executive Officer

University of Virginia Darden School of Business College/University

Phillip Lynch

Graduate Degree

Innovation Angel Foundation, Inc.

Garner William

Peter Laurence Molloy

Director/Board Member

Director/Board Member

Medical/Nursing Services

Christopher Ntoumenopoulos

Chief Executive Officer

Biotechnology

Ajay Duggal

Corporate Officer/Principal

Biotechnology

David Fuller

Chairman

Engineering & Construction

Darryl Flukes

Chairman

NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED Biotechnology

Christopher Ntoumenopoulos

Chairman

Biotechnology

Michelle Rashford

Chief Tech/Sci/R&D Officer

Biotechnology

Damian Clarke-Bruce

Chief Executive Officer

Twenty 1 Corporate Pty Ltd.

Christopher Ntoumenopoulos

Corporate Officer/Principal

TRYPTAMINE THERAPEUTICS LIMITED Pharmaceuticals: Major

Garner William

Christopher Ntoumenopoulos

Founder

Director/Board Member

Financial Conglomerates

Stephen Thornhill

Director/Board Member

Commercial Printing/Forms

Christopher Ntoumenopoulos

Chief Executive Officer

Miscellaneous Commercial Services

Phillip Lynch

Chairman

Statistics

International

Australia 32
United States 7
United Kingdom 5
Sweden 2
Netherlands 2

Sectoral

Health Technology 19
Consumer Services 12
Commercial Services 6
Technology Services 4
Finance 4

Operational

Director/Board Member 57
Corporate Secretary 30
Corporate Officer/Principal 23
Chief Executive Officer 23
Chairman 18
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW